Osaka, Japan

Mariyo Kato

This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Rohto Pharmaceutical Co., Ltd.. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mariyo Kato. Retrieved from https://idiyas.com/inventor/mariyo-kato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Mariyo Kato

Introduction

Mariyo Kato is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of ophthalmology through his innovative patents. With a total of 2 patents, Kato's work focuses on improving treatments for retinal diseases.

Latest Patents

Kato's latest patents include an agent for the prevention, improvement, or treatment of retinal disease. This prophylactic, ameliorating, or therapeutic agent comprises geranylgeranylacetone. Additionally, he has developed an ophthalmic composition that includes lecithin and at least one refrigerant selected from camphor, borneol, eucalyptus oil, and bergamot oil. This composition effectively masks the odor of lecithin, even after aging, thanks to the volatile nature of the refrigerant.

Career Highlights

Mariyo Kato is currently associated with Rohto Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has the potential to significantly impact the treatment of retinal diseases, showcasing his dedication to improving patient outcomes.

Collaborations

Kato collaborates with talented individuals such as Yasuko Matsumura and Takahiro Kurose, contributing to a dynamic research environment.

Conclusion

Mariyo Kato's innovative work in ophthalmology highlights his commitment to advancing medical treatments. His patents reflect a deep understanding of the complexities involved in treating retinal diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…